VCNX Stock Discussion
Vaccinex, Inc. Description
Vaccinex Inc. is a clinical-stage biotechnology company engaged in the discovery and development of targeted biotherapeutics. The Company is focused on providing treatments for serious diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. It provides SEMA4D antibody platform, which is focused on developing its lead product candidate VX15/2503 (VX15) for the treatment of non-small cell lung cancer, NSCLC, osteosarcoma, melanoma and Huntington’s disease. It also provides ActiveMAb antibody discovery platform, a human antibody discovery platform used for expressing large and diverse libraries of high affinity, full-length human monoclonal antibodies on the surface of vaccinia, a mammalian virus. Its product candidate VX5 is in preclinical development for the treatment of multiple sclerosis and potentially for other autoimmune disorders.
Industry: Biotechnology
Keywords: Biotechnology Cancer Biology Immunology Immune System Clinical Development Antibodies Monoclonal Antibodies Antibody Non Small Cell Lung Cancer Melanoma Small Cell Lung Cancer Neurodegenerative Diseases Multiple Sclerosis Sarcoma Autoimmune Disorders Degenerative Disease Immune Disorders NSCLC Treatment Of Non Small Cell Lung Cancer Human Monoclonal Antibodies Treatment Of Multiple Sclerosis Osteosarcoma Seth Lederman Vaccinia
Recent Comments
- TraderMike on Bollinger Band Squeeze
- TraderMike on Bollinger Band Squeeze
- OpenCat584 on Bollinger Band Squeeze
- Dr_Duru on Expansion Breakout
- TraderMike on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
From the Blog
Featured Articles